13-Methoxy-LSD
Pharmaceutical compound
From Wikipedia, the free encyclopedia
13-Methoxy-LSD is a lysergamide related to lysergic acid diethylamide (LSD).[1] It is the derivative of LSD with a methoxy group at the 13 position and is the O-methyl ether of 13-hydroxy-LSD.[1] Similarly to 13-hydroxy-LSD and other related compounds like 12-hydroxy-LSD and 12-methoxy-LSD, 13-methoxy-LSD has been reported to produce LSD-like electroencephalogram (EEG) changes in rabbits.[1] Conversely, 14-methoxy-LSD was inactive.[1] 13-Methoxy-LSD was first described in the scientific literature by 1979.[1]
Other names13-Methoxylysergic acid diethylamide; 13-OMe-LSD; 13-MeO-LSD; N,N-Diethyl-13-methoxy-6-methyl-9,10-didehydroergoline-8β-carboxamide
ATC code
- None
FormulaC21H27N3O2
| Clinical data | |
|---|---|
| Other names | 13-Methoxylysergic acid diethylamide; 13-OMe-LSD; 13-MeO-LSD; N,N-Diethyl-13-methoxy-6-methyl-9,10-didehydroergoline-8β-carboxamide |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C21H27N3O2 |
| Molar mass | 353.466 g·mol−1 |
| 3D model (JSmol) | |
| |
| |